Experiment: 6O6W

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D 1H,15N-HSQC NOESY	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Varian VNS 800
2	3D 1H,13C-HSQC NOESY aliphatic	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Varian VNS 800
3	3D 1H,13C-HSQC NOESY aromatic	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Varian VNS 800
4	2D 1H-15N HSQC	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Bruker AVANCE III 600
5	2D 1H-13C HSQC aliphatic	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Bruker AVANCE III 600
6	2D 1H-13C HSQC aromatic	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Varian VNS 800
7	3D CBCA(CO)NH	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Bruker AVANCE III 600
8	3D HNCACB	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Bruker AVANCE III 600
9	3D HNCO	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Bruker AVANCE III 600
10	3D C(CO)NH	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Bruker AVANCE III 600
11	3D HBHA(CO)NH	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Bruker AVANCE III 600
12	3D HCCH-TOCSY aliphatic	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Bruker AVANCE III 600
13	3D H(CCO)NH	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Bruker AVANCE III 600
14	2D (HB)CB(CGCD)HD aromatic	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Varian VNS 800
15	2D (HB)CB(CGCDCE)HDHE aromatic	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Varian VNS 800
16	3D HCCH-TOCSY aromatic	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Varian VNS 600
20	3D 1H,15N-HSQC NOESY 1H,13C-HSQC	8.25 mg/mL U-15N; U-13C; NA-H MYDGF, 9 mM NA sodium phosphate, 135 mM NA sodium chloride, 15 uM NA DSS, 0.02 % w/v NA sodium azide	90% H2O/10% D2O	135 (NaCl) mM	6	1 atm	298	Bruker AVANCE III 900

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	VNS	800
2	Bruker	AVANCE III	600
3	Bruker	AVANCE III	900
4	Varian	VNS	600

NMR Refinement
Method	Details	Software
molecular dynamics	explicit water refinement	PONDEROSA-C/S
molecular dynamics	explicit water refinement	X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	all calculated structures submitted
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	VNMR	4.2	Varian
2	collection	TopSpin	3.5	Bruker Biospin
3	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4	chemical shift assignment	NMRFAM-SPARKY		W. Lee, M. Tonelli and J.L. Markley
5	chemical shift assignment	I-PINE		W. Lee, A. Bahrami, H. Dashti, H.R. Eghbalnia, M. Tonelli, W.M. Westler, J.L. Markley
6	peak picking	NMRFAM-SPARKY		W. Lee, M. Tonelli and J.L. Markley
7	structure calculation	PONDEROSA-C/S		W. Lee, J.L. Stark, J.L. Markley
8	structure calculation	TALOS-N		Shen and Bax
9	structure calculation	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore
10	refinement	PyMOL		Schroedinger, Inc.
11	refinement	PONDEROSA-C/S		W. Lee, J.L. Stark, J.L. Markley
12	refinement	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.